FDA cites Tennessee company for meningitis light therapy device

As the fungal meningitis outbreak continues, the FDA is citing a Tennessee company for allegedly marketing, without proper regulatory approval, a medical device it claims can cure or treat the condition. Regulators say The Avalon Effect's Quantum Series Personal Wellness Pack qualifies as a medical device under the law, and that Avalon should have submitted a 510(k) prior to selling it. The company claims the device can also treat methicillin-resistant Staphylococcus aureus (MRSA), concussions and Lyme disease. Meanwhile, a meningitis outbreak caused by a drug compounder in Massachusetts continues to have repercussions. Release

Suggested Articles

Babson Diagnostics has closed its series A funding round with a total of $13.7 million and named a new CEO.

The FDA has authorized its first COVID-19 antibody test for use in doctors' offices, urgent care centers and emergency rooms.

The clinical testing giant LabCorp will now begin rolling out a blood test for lung cancer developed by Resolution Bioscience.